Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina.

The pharmacogenomics journal - 1 Jul 2017

Moya G, Dorado P, Ferreiro V, Naranjo M E G, Peñas-Lledó E M, LLerena A

Abstract excerpt

A twofold higher frequency of CYP2D6 ultrarapid metabolizers (estimated from genotype: gUMs) was reported among Ashkenazi Jews (AJ) living in New York (USA) than in other North American Caucasians, which might be important to guide the prescription for CYP2D6 substrates in AJ communities around the world. This study was aimed to determine whether the high frequency of CYP2D6 gUMs described in AJ from USA was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Argentina
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Genotype

Share to Phenotype

Share to Racial Groups

Source

Identifiers

PMID: 27068265
DOI: 10.1038/tpj.2016.27

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina.PMID 27068265Read ↗

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.Semantic proximity Read ↗

Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.Semantic proximity Read ↗

CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico.Semantic proximity Read ↗

High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies.Semantic proximity Read ↗

Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations.Semantic proximity Read ↗

Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants.Semantic proximity Read ↗

The Metabolization Profile of the CYP2D6 Gene in Amerindian Populations: A Review.Semantic proximity Read ↗

CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas.Semantic proximity Read ↗

High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations.Semantic proximity Read ↗

Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.Semantic proximity Read ↗

Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population.Semantic proximity Read ↗

CYP2D6 in Amerindians from Southern Mexico: low variability and higher frequency of functional alleles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.